Straumann Holding AG banner

Straumann Holding AG
SIX:STMN

Watchlist Manager
Straumann Holding AG Logo
Straumann Holding AG
SIX:STMN
Watchlist
Price: 88.14 CHF -1.37% Market Closed
Market Cap: CHf14.1B

EV/EBIT

21.4
Current
28%
Cheaper
vs 3-y average of 29.6

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
21.4
=
Enterprise Value
CHf14.3B
/
EBIT
CHf654.6m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
21.4
=
Enterprise Value
CHf14.3B
/
EBIT
CHf654.6m

Valuation Scenarios

Straumann Holding AG is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (29.6), the stock would be worth CHf121.72 (38% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-9%
Maximum Upside
+57%
Average Upside
25%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 21.4 CHf88.14
0%
3-Year Average 29.6 CHf121.72
+38%
5-Year Average 33.7 CHf138.7
+57%
Industry Average 24.1 CHf99.09
+12%
Country Average 19.5 CHf80.38
-9%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
CHf14.3B
/
Jan 2026
CHf654.6m
=
21.4
Current
CHf14.3B
/
Dec 2026
CHf665.8m
=
21.4
Forward
CHf14.3B
/
Dec 2027
CHf757.2m
=
18.8
Forward
CHf14.3B
/
Dec 2028
CHf853.1m
=
16.7
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
CH
Straumann Holding AG
SIX:STMN
14.2B CHF 21.4 39.5
US
Abbott Laboratories
NYSE:ABT
161B USD 19 25.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.3B USD 56.5 60.6
US
Stryker Corp
NYSE:SYK
125.2B USD 24.1 38.9
IE
Medtronic PLC
NYSE:MDT
105.2B USD 18.7 23.1
US
Boston Scientific Corp
NYSE:BSX
88.3B USD 26.3 33
DE
Siemens Healthineers AG
XETRA:SHL
41.6B EUR 15.6 19.7
US
Edwards Lifesciences Corp
NYSE:EW
46.3B USD 26.3 44
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.4B USD 33.9 43.4
US
Becton Dickinson and Co
NYSE:BDX
44.6B USD 16.8 25.1
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
32.9B USD 13.6 15.6

Market Distribution

In line with most companies in Switzerland
Percentile
55th
Based on 894 companies
55th percentile
21.4
Low
0 — 13.5
Typical Range
13.5 — 25.3
High
25.3 —
Distribution Statistics
Switzerland
Min 0
30th Percentile 13.5
Median 19.5
70th Percentile 25.3
Max 855.5

Straumann Holding AG
Glance View

Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale. The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.

STMN Intrinsic Value
110.4 CHF
Undervaluation 20%
Intrinsic Value
Price CHf88.14
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett